Retatrutide

What is Retatrutide?

In simple terms: Retatrutide is the "triple threat" — it activates three different hormone receptors (GIP, GLP-1, and glucagon) instead of just one or two. This triple action makes it one of the most promising compounds being studied for weight loss and metabolic health.

Technically, this is a novel triple agonist peptide targeting GIP, GLP-1, and glucagon receptors simultaneously. This creates synergistic effects on energy expenditure, appetite suppression, and glucose regulation.

Research Applications

• Next-generation obesity research
• Triple incretin signaling studies
• Energy expenditure investigation
• Comparative metabolic research